558 related articles for article (PubMed ID: 35475455)
1.
Algarni A; Pilkington EH; Suys EJA; Al-Wassiti H; Pouton CW; Truong NP
Biomater Sci; 2022 May; 10(11):2940-2952. PubMed ID: 35475455
[TBL] [Abstract][Full Text] [Related]
2. Comparison of DLin-MC3-DMA and ALC-0315 for siRNA Delivery to Hepatocytes and Hepatic Stellate Cells.
Ferraresso F; Strilchuk AW; Juang LJ; Poole LG; Luyendyk JP; Kastrup CJ
Mol Pharm; 2022 Jul; 19(7):2175-2182. PubMed ID: 35642083
[TBL] [Abstract][Full Text] [Related]
3. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
J Chem Inf Model; 2021 Oct; 61(10):5192-5202. PubMed ID: 34546048
[TBL] [Abstract][Full Text] [Related]
4. Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA.
Kulkarni JA; Myhre JL; Chen S; Tam YYC; Danescu A; Richman JM; Cullis PR
Nanomedicine; 2017 May; 13(4):1377-1387. PubMed ID: 28038954
[TBL] [Abstract][Full Text] [Related]
5. Ionizable amino lipid interactions with POPC: implications for lipid nanoparticle function.
Ramezanpour M; Schmidt ML; Bodnariuc I; Kulkarni JA; Leung SSW; Cullis PR; Thewalt JL; Tieleman DP
Nanoscale; 2019 Aug; 11(30):14141-14146. PubMed ID: 31334542
[TBL] [Abstract][Full Text] [Related]
6. Intracellular trafficking kinetics of nucleic acid escape from lipid nanoparticles via fluorescence imaging.
M Bailey-Hytholt C; Ulinski G; Dugas J; Haines M; Lazebnik M; Piepenhagen P; E Zarraga I; Bandekar A
Curr Pharm Biotechnol; 2023 Apr; ():. PubMed ID: 37016519
[TBL] [Abstract][Full Text] [Related]
7. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
[TBL] [Abstract][Full Text] [Related]
8. pH-dependent structural transitions in cationic ionizable lipid mesophases are critical for lipid nanoparticle function.
Philipp J; Dabkowska A; Reiser A; Frank K; Krzysztoń R; Brummer C; Nickel B; Blanchet CE; Sudarsan A; Ibrahim M; Johansson S; Skantze P; Skantze U; Östman S; Johansson M; Henderson N; Elvevold K; Smedsrød B; Schwierz N; Lindfors L; Rädler JO
Proc Natl Acad Sci U S A; 2023 Dec; 120(50):e2310491120. PubMed ID: 38055742
[TBL] [Abstract][Full Text] [Related]
9. DOPC
Ermilova I; Swenson J
Phys Chem Chem Phys; 2020 Dec; 22(48):28256-28268. PubMed ID: 33295352
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of clinically-approved ionizable cationic lipids shows divergent results between mRNA transfection and vaccine efficacy.
Escalona-Rayo O; Zeng Y; Knol RA; Kock TJF; Aschmann D; Slütter B; Kros A
Biomed Pharmacother; 2023 Sep; 165():115065. PubMed ID: 37406506
[TBL] [Abstract][Full Text] [Related]
11. CHARMM-GUI Membrane Builder for Lipid Nanoparticles with Ionizable Cationic Lipids and PEGylated Lipids.
Park S; Choi YK; Kim S; Lee J; Im W
bioRxiv; 2021 Jun; ():. PubMed ID: 34189527
[TBL] [Abstract][Full Text] [Related]
12. Flash nanoprecipitation assisted self-assembly of ionizable lipid nanoparticles for nucleic acid delivery.
Misra B; Hughes KA; Pentz WH; Samart P; Geldenhuys WJ; Bobbala S
Nanoscale; 2024 Apr; 16(14):6939-6948. PubMed ID: 38511623
[TBL] [Abstract][Full Text] [Related]
13. Unsaturated, Trialkyl Ionizable Lipids are Versatile Lipid-Nanoparticle Components for Therapeutic and Vaccine Applications.
Lam K; Leung A; Martin A; Wood M; Schreiner P; Palmer L; Daly O; Zhao W; McClintock K; Heyes J
Adv Mater; 2023 Apr; 35(15):e2209624. PubMed ID: 36680477
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-Catalyzed One-Step Synthesis of Ionizable Cationic Lipids for Lipid Nanoparticle-Based mRNA COVID-19 Vaccines.
Li Z; Zhang XQ; Ho W; Li F; Gao M; Bai X; Xu X
ACS Nano; 2022 Nov; 16(11):18936-18950. PubMed ID: 36269150
[TBL] [Abstract][Full Text] [Related]
15. Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo.
Lee JB; Zhang K; Tam YY; Tam YK; Belliveau NM; Sung VY; Lin PJ; LeBlanc E; Ciufolini MA; Rennie PS; Cullis PR
Int J Cancer; 2012 Sep; 131(5):E781-90. PubMed ID: 22095615
[TBL] [Abstract][Full Text] [Related]
16. Rational design of cationic lipids for siRNA delivery.
Semple SC; Akinc A; Chen J; Sandhu AP; Mui BL; Cho CK; Sah DW; Stebbing D; Crosley EJ; Yaworski E; Hafez IM; Dorkin JR; Qin J; Lam K; Rajeev KG; Wong KF; Jeffs LB; Nechev L; Eisenhardt ML; Jayaraman M; Kazem M; Maier MA; Srinivasulu M; Weinstein MJ; Chen Q; Alvarez R; Barros SA; De S; Klimuk SK; Borland T; Kosovrasti V; Cantley WL; Tam YK; Manoharan M; Ciufolini MA; Tracy MA; de Fougerolles A; MacLachlan I; Cullis PR; Madden TD; Hope MJ
Nat Biotechnol; 2010 Feb; 28(2):172-6. PubMed ID: 20081866
[TBL] [Abstract][Full Text] [Related]
17. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells.
Basha G; Novobrantseva TI; Rosin N; Tam YY; Hafez IM; Wong MK; Sugo T; Ruda VM; Qin J; Klebanov B; Ciufolini M; Akinc A; Tam YK; Hope MJ; Cullis PR
Mol Ther; 2011 Dec; 19(12):2186-200. PubMed ID: 21971424
[TBL] [Abstract][Full Text] [Related]
18. Ionizable lipids penetrate phospholipid bilayers with high phase transition temperatures: perspectives from free energy calculations.
Ermilova I; Swenson J
Chem Phys Lipids; 2023 Jul; 253():105294. PubMed ID: 37003484
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic Studies of an Automated Lipid Nanoparticle Reveal Critical Pharmaceutical Properties Associated with Enhanced mRNA Functional Delivery In Vitro and In Vivo.
Cui L; Hunter MR; Sonzini S; Pereira S; Romanelli SM; Liu K; Li W; Liang L; Yang B; Mahmoudi N; Desai AS
Small; 2022 Mar; 18(9):e2105832. PubMed ID: 34914866
[TBL] [Abstract][Full Text] [Related]
20. Novel lipid combination for delivery of plasmid DNA to immune cells in the spleen.
Kimura S; Khalil IA; Elewa YHA; Harashima H
J Control Release; 2021 Feb; 330():753-764. PubMed ID: 33422500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
